Baku 27° C
BioNTech, Pfizer studying new COVID variant
Health
- 26 November, 2021
- 13:30
BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.
“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.
The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.
Author
Latest News
13:59
Photo
U17 World Championships: Fatima Bayramova eliminated in quarterfinals
Individual sports13:55
Rafig Huseynov: Young wrestlers will become Azerbaijan's Olympic hopes
Individual sports13:50
Azerbaijan's black metal export revenues up over 30% in 1H26
Business13:38
U17 World Championships: Gulkhanim Shirinova loses to Tunisian opponent
Individual sports13:27
Azerbaijani ambassador to Pakistan completes his diplomatic mission
Foreign policy13:15
Nuray Jafarli defeated in U17 Worlds quarterfinal in Baku
Individual sports13:02
Pashinyan announces Armenian government to resign Aug. 2
Region12:54
Simura Abdullayeva loses first match at U17 World Championships in Baku
Individual sports12:49